U.S. House panel approves three bills aimed at tackling high drug prices

Published by

By Diane Bartz WASHINGTON (Reuters) – The U.S. House Judiciary Committee voted on Wednesday to approve three bills to stop practices drugmakers use to raise prices and fend off competition, including a bill to ban the tactic of paying generic companies to delay bringing cheaper versions of their medicines to market. While the votes were not unanimous, they passed the committee by a big margin. A fourth measure is set to be considered on Thursday. Committee Chairman Jerrold Nadler said the Congressional Budget Office had estimated that banning so-called pay-for-delay patent deals used to stall …

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *